Colorado’s Department of Revenue Finalized Rules and Regulations for Psychedelic-Assisted Therapy
- RHIZE
- Aug 28, 2024
- 2 min read
Colorado Advances in Psychedelic Therapy: A New Era of Mental Health Care
Colorado is paving the way for a groundbreaking approach to mental health with the finalization of regulations for psychedelic-assisted therapy. As of 2025, licensed healing centers across the state will offer psilocybin therapy, utilizing the natural healing properties of magic mushrooms like Amanita Muscaria and Pantherina. This marks a significant shift in how mental health care is delivered, moving away from traditional symptom management to a model that empowers patients to unlock their own healing potential.
Decriminalize the personal possession, growing, sharing, and use, but not the
sale, of five natural psychedelic substances by individuals aged 21 and over, including two substances found in psychedelic mushrooms — psilocybin and psilocin — and three plant based psychedelic substances — dimethyltryptamine, ibogaine, and mescaline.
A New Therapeutic Model: Proposition 122 Passed in 2022,
Unlike traditional therapies, Colorado’s psilocybin program is designed to be fully guided and supervised.
Licensed facilitators will lead these sessions, which are required to last a minimum of three hours, ensuring that patients receive thorough and compassionate care.
Importantly, psilocybin will not be available for retail purchase; instead, all treatments will take place within regulated healing centers.
Psilocybin: Colorado Regulations and Safety Measures
The state has meticulously crafted rules to ensure the safety and effectiveness of this new therapeutic model.
Businesses involved in the cultivation, manufacturing, and administration of psilocybin will need to adhere to strict guidelines.
Licensing for these businesses begins on December 31, 2024, with the first healing centers expected to open by mid-2025.
“Colorado is setting the standard for responsible and effective psychedelic therapy,” says Del Rhize, CEO of RHIZE Mushroom LLC. “This approach not only prioritizes patient safety but also respects the profound impact that psilocybin can have on mental health.”
To further ensure safety, Colorado’s regulations include:
Comprehensive health screenings and require that therapy sessions be conducted by trained professionals.
Product packaging is designed to minimize appeal to children, addressing concerns about accidental ingestion.
Education and Integration: Preparing for the Future
As Colorado prepares to launch its psilocybin therapy program, there is a strong emphasis on education and integration. The state is working to inform both the public and mental health professionals about the benefits and proper use of psychedelic therapies.
“At RHIZE, we believe in the power of education and safe practice when it comes to natural medicine,” adds Del. “This program is a testament to what can be achieved when innovation meets responsibility.”
Colorado’s approach to psychedelic therapy is not just about offering a new treatment; it’s about transforming how we think about mental health care. By focusing on safety, education, and integration, the state is laying the groundwork for a more holistic and effective model of care.
Disclaimer: RHIZE Mushroom does not sell or distribute psilocybin products. Our offerings are limited to legal Amanita Muscaria blends, which are not regulated as psilocybin. Please consult with a licensed professional for guidance on psilocybin therapies.
Comentarios